| 2026-10-19 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Bdf-gestion
|
21,258 |
18,865 |
-11.26 |
| 2026-10-19 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
Ares Financial Consulting, LLC
|
11 |
11 |
0.00 |
| 2026-10-19 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
BankChampaign, National Association
|
|
9,150 |
|
| 2026-10-19 |
13F |
SUPN / Supernus Pharmaceuticals, Inc.
/ Supernus Pharmaceuticals
|
Private Wealth Management Group, LLC
|
|
284 |
|
| 2026-10-19 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Private Wealth Management Group, LLC
|
125 |
125 |
0.00 |
| 2026-10-19 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
PUREfi Wealth, LLC
|
|
4,035 |
|
| 2026-10-19 |
13F |
SUPN / Supernus Pharmaceuticals, Inc.
/ Supernus Pharmaceuticals
|
UMB Private Wealth Management, LLC
|
|
80 |
|
| 2026-10-19 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
UMB Private Wealth Management, LLC
|
|
69 |
|
| 2026-10-19 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
UMB Private Wealth Management, LLC
|
|
5 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
TD Waterhouse Canada Inc.
|
81,697 |
80,602 |
-1.34 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Vontobel Holding Ltd.
|
4,913 |
5,038 |
2.54 |
| 2026-10-16 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
USA Financial Portformulas Corp
|
|
537 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
USA Financial Portformulas Corp
|
|
3,290 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Alpine Bank Wealth Management
|
82 |
82 |
0.00 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Frank, Rimerman Advisors LLC
|
10,493 |
10,493 |
0.00 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Align Financial, LLC
|
|
8 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Strata Wealth Advisors, LLC
|
12,640 |
12,658 |
0.14 |
| 2026-10-16 |
13F |
ASRT / Assertio Holdings, Inc.
/ Assertio Holdings
|
IFP Advisors, Inc
|
5 |
0 |
-100.00 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Brown, Lisle/cummings, Inc.
|
153 |
153 |
0.00 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
IFP Advisors, Inc
|
1,188 |
1,186 |
-0.17 |
| 2026-10-16 |
13F |
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
/ Akari Therapeutics, Plc - Depositary Receipt
|
IFP Advisors, Inc
|
181 |
181 |
0.00 |
| 2026-10-16 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
IFP Advisors, Inc
|
1 |
1 |
0.00 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
James T. Borello RIA
|
237 |
239 |
0.84 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
James T. Borello RIA
|
239 |
240 |
0.42 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
James T. Borello RIA
|
240 |
248 |
3.33 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
James T. Borello RIA
|
|
237 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Pension & Wealth Management Advisors, Inc.
|
852 |
876 |
2.82 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
James T. Borello RIA
|
248 |
259 |
4.44 |
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Concurrent Investment Advisors, LLC
|
|
74,307 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Cornerstone Planning Group LLC
|
373 |
0 |
-100.00 |
| 2026-10-16 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
Cornerstone Planning Group LLC
|
9 |
0 |
-100.00 |
| 2026-10-16 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
Y-Intercept (Hong Kong) Ltd
|
34,505 |
0 |
-100.00 |
| 2026-10-16 |
13F |
SUPN / Supernus Pharmaceuticals, Inc.
/ Supernus Pharmaceuticals
|
Y-Intercept (Hong Kong) Ltd
|
|
45,724 |
|
| 2026-10-16 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
ASR Vermogensbeheer N.V.
|
122,222 |
123,539 |
1.08 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
AdvisorNet Financial, Inc
|
41 |
0 |
-100.00 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
V-Square Quantitative Management LLC
|
6,318 |
0 |
-100.00 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
V-Square Quantitative Management LLC
|
|
6,440 |
|
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Activest Wealth Management
|
17 |
0 |
-100.00 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Newbridge Financial Services Group, Inc.
|
|
2 |
|
| 2026-10-15 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
Newbridge Financial Services Group, Inc.
|
600 |
600 |
0.00 |
| 2026-10-15 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
Ellsworth Advisors, LLC
|
9,914 |
0 |
-100.00 |
| 2026-10-15 |
13F |
SUPN / Supernus Pharmaceuticals, Inc.
/ Supernus Pharmaceuticals
|
Ellsworth Advisors, LLC
|
|
18,121 |
|
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Ronald Blue Trust, Inc.
|
640 |
0 |
-100.00 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Ronald Blue Trust, Inc.
|
|
44 |
|
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Curated Wealth Partners LLC
|
|
3,508 |
|
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Elevated Private Wealth, LLC
|
25,886 |
24,540 |
-5.20 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Ninety One UK Ltd
|
9,537 |
5,186 |
-45.62 |
| 2026-10-15 |
13F |
SUPN / Supernus Pharmaceuticals, Inc.
/ Supernus Pharmaceuticals
|
State of Alaska, Department of Revenue
|
|
22,847 |
|
| 2026-10-15 |
13F |
ANIP / ANI Pharmaceuticals, Inc.
/ ANI Pharmaceuticals
|
State of Alaska, Department of Revenue
|
7,375 |
4,499 |
-39.00 |
| 2026-10-15 |
13F |
RPRX / Royalty Pharma plc
/ Royalty Pharma
|
Triasima Portfolio Management inc.
|
180,710 |
223,527 |
23.69 |